Yep, sounds reasonable to me, really want to see some solid Q3 revenue growth, after the poor Q2 revenue growth that would go a long way to reassuring the market. When I talk to medical friends about the product, it definitely sounds like a growth area so happy I'm still holding
Ann: Preliminary and Annual Report to shareholders, page-5
Add UCM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.506M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 180000 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 36903 | 1 |
View Market Depth
| Last trade - 10.08am 02/10/2024 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable